Aficamten for Obstructive Hypertrophic Cardiomyopathy | NEJM

Описание к видео Aficamten for Obstructive Hypertrophic Cardiomyopathy | NEJM

Whether the reversible cardiac myosin inhibitor aficamten can improve peak oxygen uptake in patients with symptomatic obstructive hypertrophic cardiomyopathy is unknown.

Research findings are summarized in a new Quick Take video.

To see the full article, follow this link: https://nej.md/3wmDzyl

#cardiology #clinicaltrials #nejm

Комментарии

Информация по комментариям в разработке